anthrax bacillus (protective antigen (PA)) antibody and antigen (Recombinant protein)
Diagnostic Bacillus anthracis antibodies (anti-anthrax bacillus, anti-protective antigen (PA)) and antigens (recombinant Bacillus anthracis protein) for Infectious disease protective antigen (PA) detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-IVD-P015-Tg001-Ag01 | Recombinant human Bacillus anthracis (B. anthracis) protective antigen (PA) Protein | 3090 |
GMP-IVD-P015-Tg001-Ab01 | Anti-human Bacillus anthracis (B. anthracis) protective antigen (PA) mouse monoclonal antibody (mAb) | 1953 |
GMP-IVD-P015-Tg001-Ab02 | Anti-human Bacillus anthracis (B. anthracis) protective antigen (PA) mouse monoclonal antibody (mAb) | 1953 |
GMP-IVD-P015-Tg001-Ab03 | Anti-human Bacillus anthracis (B. anthracis) protective antigen (PA) human monoclonal antibody (mAb) | 1953 |
GMP-IVD-P015-Tg001-Ab04 | Anti-human Bacillus anthracis (B. anthracis) protective antigen (PA) human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-IVD-P015-Tg001-Ag01 |
Product Name | Recombinant human Bacillus anthracis (B. anthracis) protective antigen (PA) Protein |
Pathogen | Bacillus anthracis |
Target/Biomarker | Bacillus anthracis (protective antigen (PA)) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | anthrax bacillus (protective antigen (PA)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in protective antigen (PA) level test of Infectious disease (Anthrax) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human Bacillus anthracis (B. anthracis) protective antigen (PA) Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-IVD-P015-Tg001-Ab01, GMP-IVD-P015-Tg001-Ab02 |
Product Name | Anti-human Bacillus anthracis (B. anthracis) protective antigen (PA) mouse monoclonal antibody (mAb) |
Pathogen | Bacillus anthracis |
Target/Biomarker | Bacillus anthracis (protective antigen (PA)) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | anthrax bacillus (protective antigen (PA)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in protective antigen (PA) level test of Infectious disease (Anthrax) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human Bacillus anthracis (B. anthracis) protective antigen (PA) mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-IVD-P015-Tg001-Ab03, GMP-IVD-P015-Tg001-Ab04 |
Product Name | Anti-human Bacillus anthracis (B. anthracis) protective antigen (PA) human monoclonal antibody (mAb) |
Pathogen | Bacillus anthracis |
Target/Biomarker | Bacillus anthracis (protective antigen (PA)) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | anthrax bacillus (protective antigen (PA)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in protective antigen (PA) level test of Infectious disease (Anthrax) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human Bacillus anthracis (B. anthracis) protective antigen (PA) human monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Anthrax is a serious infectious disease caused by gram-positive, rod-shaped bacteria known as Bacillus anthracis. It occurs naturally in soil and commonly affects domestic and wild animals around the world. People can get sick with anthrax if they come in contact with infected animals or contaminated animal products.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments